Kala Gets the Greenlight from FDA for Dry Eye Disease Treatment
The Pharma Data
OCTOBER 26, 2020
Food and Drug Administration (FDA) has approved EYSUVIS for the short-term treatment of dry eye disease. . EYSUVIS is the first FDA-approved corticosteroid specifically for dry eye disease treatment. Over-the-counter treatments fail due to the body’s natural protective system. Roughly 16.4
Let's personalize your content